Sanofi India Faces Rs 23.74 Crore GST Demand Over Alleged Excess ITC Claim for FY23 - Medical Dialogues
Sanofi India Faces Rs 23.74 Crore GST Demand Over Alleged Excess ITC Claim for FY23 Medical Dialogues
Why this GST update matters
This article highlights a GST-related development that may be relevant for understanding regulatory trends, compliance focus areas, or policy interpretation. Tracking such updates helps readers stay informed about how GST rules and enforcement practices continue to evolve.